Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer

Cancer

Volumn 119, Issue 20, 2013, Pages 3619-3628

  Quek, Ruben G W ^a   Master, Viraj A ^b   Ward, Kevin C ^a   Lin, Chun Chieh ^c   Virgo, Katherine S ^a   Portier, Kenneth M ^a   Lipscomb, Joseph ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

Author keywords

brachytherapy; epidemiologic factors; Health Services Research; prostatic neoplasms; radiotherapy

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BRACHYTHERAPY; CANCER CLASSIFICATION; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DATA BASE; EUROPEAN AMERICAN; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; ONCOLOGIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RETROSPECTIVE STUDY; UNITED STATES;

BRACHYTHERAPY; EPIDEMIOLOGIC FACTORS; HEALTH SERVICES RESEARCH; PROSTATIC NEOPLASMS; RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICAL ONCOLOGY; MEDICARE; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84885189319     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28258     Document Type: Article

References (37)

1. Albertsen PC, Moore DF, Shih WC, Lin Y, Li H, Lu-Yao GL,. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol. 2011; 29: 1335-1341.
2. Emory University, American Cancer Society. tinyurl.com/CancerIdea3AddRef. Accessed May 17, 2013.
3. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR,. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004; 22: 2141-2149. (Pubitemid 41095147)
4. Hamilton AS, Albertsen PC, Johnson TK, et al. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int. 2011; 107: 576-584.
5. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML,. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008; 100: 888-897. (Pubitemid 351881955)
6. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969-974. (Pubitemid 28445094)
7. Merrick GS, Butler WM, Wallner KE, et al. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005; 61: 32-43. (Pubitemid 40039102)
8. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008; 358: 1250-1261. (Pubitemid 351439226)
9. Nguyen PL, Gu XM, Lipsitz SR, et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol. 2011; 29: 1517-1524.
10. Falit BP, Gross CP, Roberts KB,. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys. 2010; 76: 1285-1288.
11. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR,. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007; 178 (3 pt 2): S14-S19. (Pubitemid 47224952)
12. Spencer BA, Fung CH, Wang M, Rubenstein LV, Litwin MS,. Geographic variation across veterans affairs medical centers in the treatment of early stage prostate cancer. J Urol. 2004; 172 (6 pt 1): 2362-2365. (Pubitemid 39507528)
13. Cooperberg MR, Broering JM, Carroll PR,. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010; 28: 1117-1123.
14. Shahinian VB, Kuo YF, Freeman JL, Orihuela E, Goodwin JS,. Characteristics of urologists predict the use of androgen deprivation therapy for prostate cancer. J Clin Oncol. 2007; 25: 5359-5365. (Pubitemid 350232210)
15. Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O,. SAS® for Mixed Models. 2nd ed. Cary, NC: SAS Institute Inc; 2006.
16. Snijders TAB, Bosker R,. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Thousand Oaks, CA: Sage; 1999.
17. Krupski TL, Kwan L, Afifi AA, Litwin MS,. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol. 2005; 23: 7881-7888. (Pubitemid 46657386)
18. McNaughton Collins M, Barry MJ, Zietman A, et al. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region. Urology. 2002; 60: 628-633. (Pubitemid 35246448)
19. Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF,. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 2004; 64: 1171-1176. (Pubitemid 39647061)
20. Underwood W 3rd, Jackson J, Wei JT, et al. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer. 2005; 103: 538-545.
21. Jha AK, Li Z, Orav EJ, Epstein AM,. Care in US hospitals-the Hospital Quality Alliance program. N Engl J Med. 2005; 353: 265-274. (Pubitemid 41058326)
22. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282: 1458-1465. (Pubitemid 29493800)
23. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF,. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002; 40 (suppl 8): IV-3-IV-18.
24. The Henry J. Kaiser Family Foundation. Medicare Chartbook, 2010. http://kaiserfamilyfoundation.files.wordpress.com/2013/01/8103.pdf. Accessed May 17, 2013.
25. Zeliadt SB, Moinpour CM, Blough DK, et al. Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care. 2010; 16: e121-e130.
26. Hershman DL, Buono D, McBride RB, Tsai WY, Neugut AI,. Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women. Cancer. 2009; 115: 3848-3857.
27. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS,. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst. 2006; 98: 839-845. (Pubitemid 43932049)
28. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Manning WG,. The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA. 1999; 281: 2098-2105. (Pubitemid 29264688)
29. Zeliadt SB, Ramsey SD, Penson DF, et al. Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer. 2006; 106: 1865-1874. (Pubitemid 43673200)
30. Shen J, Andersen R, Brook R, Kominski G, Albert PS, Wenger N,. The effects of payment method on clinical decision-making: physician responses to clinical scenarios. Med Care. 2004; 42: 297-302.
31. Mitchell JM, Sass TR,. Physician ownership of ancillary services: indirect demand inducement or quality assurance? J Health Econ. 1995; 14: 263-289.
32. Mitchell JM,. Do financial incentives linked to ownership of specialty hospitals affect physicians' practice patterns? Med Care. 2008; 46: 732-737.
33. Gazelle GS, Halpern EF, Ryan HS, Tramontano AC,. Utilization of diagnostic medical imaging: comparison of radiologist referral versus same-specialty referral. Radiology. 2007; 245: 517-522. (Pubitemid 47612534)
34. Mitchell JM,. Effect of physician ownership of specialty hospitals and ambulatory surgery centers on frequency of use of outpatient orthopedic surgery. Arch Surg. 2010; 145: 732-738.
35. Mitchell JM,. Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection. Health Aff (Millwood). 2012; 31: 741-749.
36. Nallamothu BK, Rogers MA, Chernew ME, Krumholz HM, Eagle KA, Birkmeyer JD,. Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries. JAMA. 2007; 297: 962-968. (Pubitemid 46376750)
37. Mitchell JM, Sunshine JH,. Consequences of physicians ownership of health care facilities-joint ventures in radiation therapy. N Engl J Med. 1992; 327: 1497-1501.